Farran Powell is the managing editor of investing at Forbes Advisor. She was previously the assistant managing editor of investing at U.S. News & World Report. Her work has appeared in numerous ...

Brendan McCann: Information pelts investors like a never-ending storm. It’s often tempting to switch things up. However, sticking to a long-term plan tends to be the better option. The following three ...

From broad domestic exposure to global pharma and biotech, these funds cover the healthcare sector's main themes.

As of April, IEV trades at a lower price-to-earnings ratio of about 17.5, compared with 25.8 for ITOT. Income is another ...

Growth stocks are driving strong market gains right now. For example, the Nasdaq-100, an index of top tech stocks, is up 22% year to date, nearly double the S&P 500's 12% gain. If you're looking for ...

SCHD returned 25% over the trailing year while paying blue-chip income at just 0.06% expense; DGRO has compounded 259% over ten years. VYM's 440-stock basket at 0.04% expense has delivered ...

One factor that drew me to this ETF is its history of providing reliable income. SPDR S&P Dividend ETF tracks the performance of the S&P High Yield Dividend ...

David Carey: Stocks have had a choppy start to 2026, but one bright spot has been international equities. They outpaced US stocks in 2025 and are off to a strong start again in 2026. Now, it’s almost ...